Vaccination of yeast sensitive individuals: review of safety date in the US vaccine adverse event reporting system (VAERS). 2006 Mar 24 24(14):2685-91.ĭiMiceli L, Pool V, Kelso JM, Shadomy SV, Iskander J VAERS Team. Adverse events after hepatitis A B combination vaccine.
#SYNDICATE PROJECT REDDIT RESPONSE SERIES#
Hepatitis B vaccination and first central nervous system demyelinating event: Reanalysis of a case-control study using the self-controlled case series method. Hocine MN, Farrington CP, Touze E, Whitaker HJ, Fourrier A, Moreau T, Tubert-Bitter P.
Hepatitis B vaccine and risk of autoimmune thyroid disease: A Vaccine Safety Datalink study.
Yu O, Bohlke K, Hanson CA, Delaney K, Rees TG, Zavitkovsky A, Ray P, Mullooly J, Black SB, Benson P, Thompson WW, Davis RL, Jackson LA. Use of Hepatitis B Vaccination for Adults with Diabetes Mellitus: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Sawyer MH, Hoerger TJ, Murphy TV, Schillie SF, Hu D, Spradling PR, Byrd KK, Xing J, Reilly ML, Tohme RA, Moorman A, Smith EA, Baack BN, Jiles RB, Klevens M, Ward JW, Kahn HS, Zhou F. CDC Guidance for Evaluating Health-Care Personnel for Hepatitis B Virus Protection and for Administering Postexposure Management. Schillie S, Murphy TV, Sawyer M, Ly K, Hughes E, Jiles R, de Perio MA, Reilly M, Byrd K, Ward JW. Assessing the safety of hepatitis B vaccination during pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 1990-2016. Moro PL, Zheteyeva Y, Barash F, Lewis P, Cano M. Safety of currently licensed hepatitis B surface antigen vaccines in the United States, Vaccine Adverse Event Reporting System (VAERS), 2005-2015. Haber P, Moro PL, Ng C, Lewis PW, Hibbs B, Schillie SF, Nelson NP, Li R, Stewart B, Cano MV. Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices. Schillie S, Vellozzi C, Reingold A, Harris A, Haber P, Ward JW, Nelson NP. Uptake and safety of Hepatitis B vaccination during pregnancy: A Vaccine Safety Datalink study. Groom HC, Irving SA, Koppolu P, Smith N, Vazquez-Benitez G, Kharbanda EO, Daley MF, Donahue JG, Getahun D, Jackson LA, Tse Kawai A, Klein NP, Nordin JD, Sukumaran L, Naleway AL. There are safe and effective vaccines that can protect against hepatitis B. Chronic hepatitis B can lead to serious health issues, like cirrhosis or liver cancer. Risk for chronic infection is related to age at infection: approximately 90% of infected infants become chronically infected, compared with 2%–6% of adults. But for others, it can become a long-term, chronic infection that might not have symptoms.
#SYNDICATE PROJECT REDDIT RESPONSE SKIN#
This can happen through sexual contact, sharing needles or other drug-injection equipment, or from mother to baby at birth. The virus can spread from an infected individual even if they do not look or feel sick.įor some people, hepatitis B is a short-term illness with symptoms that can include fever, tiredness, loss of appetite, nausea, vomiting, jaundice, abdominal pain, dark urine, clay-colored bowel movements, joint pain, and jaundice (yellow color in the skin or eyes). It is spread when infected blood, semen, or other body fluids enters the body of a person who is not infected.
Hepatitis B is a liver infection caused by the hepatitis B virus.
0 kommentar(er)
